JBIO

Analyst Sentiment

Wall St. Consensus
Buy
4 analysts·Low coverage
75
Score
4 Buy (100%)0 Hold (0%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
4100%
Hold
00%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$32.00
+37.0%
Consensus
$37.00
+58.4%
Bull
$45.00
+92.7%
12-Month Target Range4 analysts
$32.00$37.00$45.00
Current $23.36Consensus
Current Price
$23.36
Upside to Consensus
$13.64

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev
EPS
FY2028
Rev
EPS
FY2029
Rev
EPS

Earnings Surprises

Recent Analyst Actions

May 11, 2026Wedbush
Jade Biosciences price target raised to $34 from $24 at Wedbush
Target:$34.00
+31.7%from $25.81
May 11, 2026Guggenheim
Jade Biosciences price target raised to $32 from $23 at Guggenheim
Target:$32.00
+24.0%from $25.81
Apr 27, 2026H.C. Wainwright
Jade Biosciences price target raised to $45 from $35 at H.C. Wainwright
Target:$45.00
+80.1%from $24.98
Mar 6, 2026Stifel Nicolaus
Jade Biosciences (JBIO) PT Raised to $40 at Stifel: "We like the setup for JADE101"
Target:$40.00
+184.4%from $14.07
Jan 7, 2026H.C. Wainwright
Jade Biosciences initiated with a Buy at H.C. Wainwright
Target:$25.00
+89.8%from $13.17
Oct 9, 2025BTIG
Jade Biosciences initiated with a Buy at BTIG
Target:$28.00
+208.4%from $9.08
Jun 16, 2025Guggenheim
Jade Biosciences upgraded to Buy from Neutral at Guggenheim
Target:$14.00
+107.1%from $6.76
May 5, 2025Stifel Nicolaus
Jade Biosciences initiated with a Buy at Stifel
Target:$19.00
+65.2%from $11.50